Literature DB >> 3981611

A simple adult-mouse test for tissue invasiveness in Yersinia enterocolitica strains of low experimental virulence.

R Bakour, G Balligand, Y Laroche, G Cornelis, G Wauters.   

Abstract

The virulence of Yersinia enterocolitica depends on the presence of a 70-kilobase plasmid, called the Vwa plasmid. This situation is particularly favourable for studies of the mechanism of pathogenicity, but these are hindered by the lack of a suitable animal test to monitor the virulence of the human-pathogenic strains isolated outside the USA which belong to serogroups O:3, O:9 and O:5,27. We observed that, after oral administration to the mouse, the Vwa-positive strains of these serogroups produce a discrete systemic infection while the Vwa-negative strains do not. We present here a simple mouse-virulence test based on this observation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981611     DOI: 10.1099/00222615-19-2-237

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  20 in total

1.  Involvement of M cells in the bacterial invasion of Peyer's patches: a common mechanism shared by Yersinia enterocolitica and other enteroinvasive bacteria.

Authors:  A Grützkau; C Hanski; H Hahn; E O Riecken
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

2.  Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit.

Authors:  M P Sory; P Hermand; J P Vaerman; G R Cornelis
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Development and testing of a synthetic oligonucleotide probe for the detection of pathogenic Yersinia strains.

Authors:  M D Miliotis; J E Galen; J B Kaper; J G Morris
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

4.  Characterization of enterocoliticin, a phage tail-like bacteriocin, and its effect on pathogenic Yersinia enterocolitica strains.

Authors:  E Strauch; H Kaspar; C Schaudinn; P Dersch; K Madela; C Gewinner; S Hertwig; J Wecke; B Appel
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

5.  Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection.

Authors:  J C Pepe; M R Wachtel; E Wagar; V L Miller
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Comparison of ceftriaxone, amikacin, and ciprofloxacin in treatment of experimental Yersinia enterocolitica O9 infection in mice.

Authors:  M Jiménez-Valera; C Gonzalez-Torres; E Moreno; A Ruiz-Bravo
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

7.  Excretion of Yersinia spp. associated with consumption of pasteurized milk.

Authors:  M H Greenwood; W L Hooper
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

8.  Human coproantibody secretory immunoglobulin A response to Yersinia species.

Authors:  K M Fletcher; C M Morris; M A Noble
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

9.  Early-onset Pseudomonas aeruginosa sepsis and Yersinia enterocolitica neonatal infection: a unique combination in a preterm infant.

Authors:  L Pacifico; C Chiesa; S Mirabella; A Panero; M Midulla
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

10.  Clinical significance of virulence-related assay of Yersinia species.

Authors:  M A Noble; R L Barteluk; H J Freeman; R Subramaniam; J B Hudson
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.